CSIMarket
Galmed Pharmaceuticals Ltd   (GLMD)
Other Ticker:  
 
 

Galmed Pharmaceuticals Ltd 's Yearly Income from Continued Operations Growth 5 Years

 

Select the Comparisons : Select the Ratio:



GLMD Annual Income from Cont. Operations Growth

2022
2021
2020
2019
2018
Y / Y Annual Income from Cont. Operations Change -44.97 % 12.85 % 40.61 % 107.6 % -19.86 %
Annual Income from Cont. Operations (in millions $) $17.87 $32.47 $28.77 $20.46 $9.86


Annual Income from Cont. Operations Growth Comment
Galmed Pharmaceuticals Ltd experienced detoriation of Annual Income from Cont. Operations for the fiscal year ended 2022 by -44.97% to $ 17.87 millions, compare to $ 32.47 in Annual Income from Cont. Operations reported in the previous year. The decline in company's annual Income from Continued Operations accelerated, from the 12.85 % gain, in the fiscal year ended 2021.

Galmed Pharmaceuticals Ltd Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2022 Annual Income from Cont. Operations within Healthcare SectorY/Y Income from Continued Operations Growth %2022 Annual Income from Cont. Operations
Sinovac Biotech Ltd -99.39 %$ 88.131  millions
Fulgent Genetics Inc -71.97 %$ 141.923  millions
Uniqure N v